![]() |
Fall 2010 Symposium |
Pre-Clinical Research in COPD and Pulmonary Fibrosis
Friday,
October 15th 2010 Pfizer Facility – Building J Andover, MA 01810
1 Burtt Road
MEETING Agenda, directions, and accomidations (PDF file)
Click Here For Online Registration, Directions, and Accommodations
Registration is Mandatory for Attendance
Presentations:
Richard Pierce : Washington University, St. Louis, MO · Airways Disease-Specific Pathways in Chronic Pulmonary Obstructive Disease (COPD). Martin Stampfli : McMaster University, Hamilton, Ontario · Cigarette smoke and respiratory host defense: Implications for smoking-related diseases. Martin Kolb: McMaster University, Hamilton, Ontario · Mesenchymal progenitor cells in lung fibrosis – News about pathogenesis and their potential clinical role. Bela Suki - Boston University, Boston, MA · Interaction Between Mechanical Forces and Elastase Activity in the Normal and Emphysematous Lung. Lynne Murray: MedImmune · Commonalities between COPD and IPF fibrosis. Thomas Wynn: NIH, Bethesda, MD · Distinct roles for IL-13 and IL-17a in pulmonary inflammation and fibrosis. Jonathan Phillips: Roche, Nutley, NJ · Increased work of breathing from bleomycin induced fibrosis in the mouse lung. Aaron Winkler, Pfizer, Andover, MA · In vitro modeling of human alveolar macrophage smoke exposure: Enhanced inflammation, impaired function, and regulation of histone deacetylases.
© Jon Phillips 2008